SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/13/20 Cell Source, Inc. 10-Q 9/30/20 50:3.2M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 398K 2: EX-10.54 Material Contract HTML 51K 3: EX-10.55 Material Contract HTML 53K 4: EX-10.56 Material Contract HTML 37K 5: EX-10.57 Material Contract HTML 36K 6: EX-10.58 Material Contract HTML 35K 7: EX-10.59 Material Contract HTML 51K 8: EX-31 Certification -- §302 - SOA'02 HTML 19K 9: EX-32 Certification -- §906 - SOA'02 HTML 15K 16: R1 Cover HTML 47K 17: R2 Condensed Consolidated Balance Sheets HTML 85K 18: R3 Condensed Consolidated Balance Sheets HTML 43K (Parenthetical) 19: R4 Condensed Consolidated Statements of Operations HTML 63K (Unaudited) 20: R5 Condensed Consolidated Statements of Changes in HTML 92K Stockholders' Deficit (Unaudited) 21: R6 Condensed Consolidated Statements of Cash Flows HTML 118K (Unaudited) 22: R7 Business Organization Nature of Operations and HTML 24K Basis of Presentation 23: R8 Going Concern and Management Plans HTML 20K 24: R9 Summary of Significant Accounting Policies HTML 25K 25: R10 Fair Value HTML 78K 26: R11 Advances Payable HTML 18K 27: R12 Notes Payable and Convertible Notes Payable HTML 27K 28: R13 Stockholders' Deficiency HTML 27K 29: R14 Related Party Transactions HTML 19K 30: R15 Commitments and Contingencies HTML 21K 31: R16 Subsequent Events HTML 21K 32: R17 Summary of Significant Accounting Policies HTML 28K (Policies) 33: R18 Summary of Significant Accounting Policies HTML 22K (Tables) 34: R19 Fair Value (Tables) HTML 69K 35: R20 Going Concern and Management Plans (Detail HTML 28K Narrative) 36: R21 Summary of Significant Accounting Policies HTML 23K (Details) 37: R22 Summary of Significant Accounting Policies (Detail HTML 19K Narrative) 38: R23 Fair Value (Details) HTML 39K 39: R24 Fair Value (Details 1) HTML 28K 40: R25 Fair value (Details 2) HTML 57K 41: R26 Fair Value (Details Narrative) HTML 21K 42: R27 Advance Payable (Details Narrative) HTML 25K 43: R28 Notes Payable and Convertible Notes Payable HTML 114K (Details Narrative) 44: R29 Stockholders Deficiency (Details Narrative) HTML 109K 45: R30 Related Party Transactions (Details Narrative) HTML 24K 46: R31 Commitments and Contingencies (Details Narrative) HTML 22K 47: R32 Subsequent Events (Details Narrative) HTML 43K 49: XML IDEA XML File -- Filing Summary XML 76K 48: EXCEL IDEA Workbook of Financial Reports XLSX 54K 10: EX-101.INS XBRL Instance -- clcs-20200930 XML 876K 13: EX-101.CAL XBRL Calculations -- clcs-20200930_cal XML 102K 15: EX-101.DEF XBRL Definitions -- clcs-20200930_def XML 404K 12: EX-101.LAB XBRL Labels -- clcs-20200930_lab XML 652K 14: EX-101.PRE XBRL Presentations -- clcs-20200930_pre XML 534K 11: EX-101.SCH XBRL Schema -- clcs-20200930 XSD 135K 50: ZIP XBRL Zipped Folder -- 0001640334-20-002809-xbrl Zip 84K
EXHIBIT 32
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Cell Source, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the quarter ended September 30, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 13, 2020
/s/ Itamar Shimrat |
|
| |
Chief Executive Officer and Chief Financial Officer |
|
(Principal Executive, Financial, and Accounting Officer) |
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/13/20 | None on these Dates | ||
For Period end: | 9/30/20 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/08/23 Cell Source, Inc. 10-K 12/31/22 77:11M M2 Compliance LLC/FA 4/15/22 Cell Source, Inc. 10-K 12/31/21 75:11M M2 Compliance LLC/FA 4/15/21 Cell Source, Inc. 10-K 12/31/20 71:6.4M Pubco Reporting … Inc/FA |